North America Aortic Valve Replacement Devices Market Forecast to 2030
North America Aortic Valve Replacement Devices Market Forecast to 2030 – Regional Analysis – by Product (Sutureless Valve and Mechanical Valve), Surgery (Minimally Invasive Surgery and Open Surgery), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others).
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Rising Number of Aortic Valve Replacement Surgeries Fuels North America Aortic Valve Replacement Devices Market
There has been a significant increase in the number of aortic valve replacement surgeries performed worldwide recently. According to data published by The Texas Herat Institute, ~106,000 heart valve procedures are performed annually in the US. The mitral or aortic valves are repaired or replaced in almost all of these procedures. This surge can be attributed to several factors, including advancements in medical technology, an aging population, and improved awareness of heart-related conditions. Aortic valve replacement is a critical procedure often used to treat aortic valve stenosis or regurgitation, conditions that can lead to serious complications if left untreated. As medical science continues to evolve, these surgeries are expected to become even safer and more accessible, contributing to better patient outcomes and improved quality of life for those affected by aortic valve diseases. Healthcare systems are adapting to accommodate this growing demand for surgical interventions, emphasizing the importance of preventive measures and early detection in managing cardiovascular health.
North America Aortic Valve Replacement Devices Market Overview
The North America aortic valve replacement devices market is segmented into the US, Canada, and Mexico. The market growth in the region is attributed to the rising prevalence of heart diseases and increasing number of regulatory approvals, R&D activities, and new product launches. Additionally, a large number of cardiac centers, specialty care centers, and ambulatory surgical centers, as well as favorable reimbursement scenarios, are expected to boost the aortic valve replacement devices market growth in North America during 2022–2030.
North America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)
North America Aortic Valve Replacement Devices Market Segmentation
The North America aortic valve replacement devices market is segmented into product, surgery, end user, and country.
Based on product, the North America aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger North America aortic valve replacement devices market share in 2022.
Based on surgery, the North America aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger North America aortic valve replacement devices market share in 2022.
Based on end user, the North America aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest North America aortic valve replacement devices market share in 2022.
Based on country, the North America aortic valve replacement devices market has been categorized into the US, Canada, and Mexico. The US dominated the North America aortic valve replacement devices market in 2022.
Abbott Laboratories; Artivion Inc; Boston Scientific Corp; Braile Biomedica Industry, Commerce and Representations Ltd; Edwards Lifesciences Corp; LivaNova Plc; Medtronic Plc; JenaValve Technology Inc; and Venus MedTech HangZhou Inc; are some of the leading companies operating in the North America aortic valve replacement devices market.
Summary Info
Industry: | |
---|---|
Pricing options: | |
Geographical coverage: | |
Year of Publication: |
According to The Research Team’ research, the North America aortic valve replacement devices market was valued at US$ 3,333.33 million in 2022 and is expected to reach US$ 8,603.28 million by 2030, registering a CAGR of 12.6% from 2022 to 2030. Rising number of aortic valve replacement surgeries and increasing demand for minimally invasive techniques are among the critical factors attributed to the North America aortic valve replacement devices market expansion.
A surge in research activity is driven by several factors, including growing prevalence of aortic valve diseases, advancements in medical technology, and need for more evidence-based approaches to treatment. Clinical studies are crucial in assessing the safety and efficacy of new surgical techniques, prosthetic valves, and transcatheter interventions. These studies also help identify risk factors, optimize patient selection criteria, and evaluate long-term outcomes to improve patient care and quality of life. As the demand for aortic valve replacement continues to rise, so does the importance of conducting robust clinical trials to provide healthcare professionals and patients with the best available evidence for making informed treatment options. With ongoing research and collaboration between medical institutions, the future of aortic valve replacement looks promising, with the potential for even more innovative and effective approaches on the horizon.
A few technological advancements by the players in the aortic valve replacement devices are mentioned below:
• Trial started in January 2019, innovative device for pain management by millimeter band radiation: electronic-pain killer (EPIKARD).
Trial started in January 2017, vascular closure device in transcatheter aortic valve replacement. Evaluation of the safety and efficacy of a percutaneous plug-based large-bore vascular closure device for femoral artery closure in an unselected consecutive patient cohort undergoing transcatheter aortic valve implantation in a single-center prospective study.
On the contrary, product recalls hurdle the growth of North America aortic valve replacement devices market.
Based on product, the North America aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve segment held 61.0% share of North America aortic valve replacement devices market in 2022, amassing US$ 2,033.02 million. It is projected to garner US$ 5,431.64 million by 2030 to expand at 13.1% CAGR during 2022–2030.
Based on surgery, the North America aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held 87.1% share of North America aortic valve replacement devices in 2022, amassing US$ 2,904.88 million. It is projected to garner US$ 7,748.76 million by 2030 to expand at 13.0% CAGR during 2022–2030.
Based on end user, the North America aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held 67.6% share of North America aortic valve replacement devices market in 2022, amassing US$ 2,251.80 million. It is projected to garner US$ 5,992.74 million by 2030 to expand at 13.0% CAGR during 2022–2030.
Based on country, the North America aortic valve replacement devices market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 85.4% share of North America aortic valve replacement devices market in 2022. It was assessed at US$ 2,847.00 million in 2022 and is likely to hit US$ 7,492.60 million by 2030, exhibiting a CAGR of 12.9% during 2022–2030.
Key players operating in the North America aortic valve replacement devices market are Abbott Laboratories; Artivion Inc; Boston Scientific Corp; Braile Biomedica Industry, Commerce and Representations Ltd; Edwards Lifesciences Corp; LivaNova Plc; Medtronic Plc; JenaValve Technology Inc; and Venus MedTech HangZhou Inc, among others.
In May 2023, Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low structural valve deterioration (SVD) rates in bioprosthetic aortic valves with the company’s innovative RESILIA tissue. The data, representing the longest clinical follow-up for Edwards’ bioprosthetic surgical aortic valve with RESILIA tissue with a mean follow-up of 7.7 years, were presented at the 103rd annual meeting of the American Association for Thoracic Surgery. In Feb 2023, Medtronic relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America aortic valve replacement devices market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the North America aortic valve replacement devices market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the aortic valve replacement devices market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Aortic Valve Replacement Devices Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
4.4 Pipeline Analysis
5. North America Aortic Valve Replacement Devices Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Rising Number of Aortic Valve Replacement Surgeries
5.1.2 Increasing Demand for Minimally Invasive Techniques
5.2 Market Restraints
5.2.1 Product Recalls
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Market Opportunities
5.3.1 Advancements in Aortic Valve Replacement Devices
5.4 Future Trends
5.4.1 Increasing Number of Clinical Studies
5.5 Impact Analysis:
6. Aortic Valve Replacement Devices Market – North America Market Analysis
6.1 North America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 – 2030
7. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 North America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Mechanical Valve
7.3.1 Overview
7.3.2 Mechanical Valve: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Sutureless Valve
7.4.1 Overview
7.4.2 Sutureless Valve: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by Surgery.
8.1 Overview
8.2 North America Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
8.3 Open Surgery
8.3.1 Overview
8.3.2 Open Surgery: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Minimally Invasive Surgery
8.4.1 Overview
8.4.2 Minimally Invasive Surgery: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 – by End User.
9.1 Overview
9.2 North America Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers
9.4.1 Overview
9.4.2 Ambulatory Surgery Centers : North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Aortic Valve Replacement Devices Market – Country Analysis
10.1 North America: Aortic Valve Replacement Devices Market
10.1.1 Overview
10.1.2 North America: North America Aortic Valve Replacement Devices Market, by Country, 2022 & 2030 (%)
10.1.2.1 US: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 US: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.1.4 US: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.1.5 US: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
10.1.2.2 Canada: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Canada: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.2.4 Canada: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.2.5 Canada: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
10.1.2.3 Mexico: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Mexico: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 Mexico: Aortic Valve Replacement Devices Market, by Product, 2020–2030 (US$ Million)
10.1.2.3.4 Mexico: Aortic Valve Replacement Devices Market, by Surgery, 2020–2030 (US$ Million)
10.1.2.3.5 Mexico: Aortic Valve Replacement Devices Market, by End User, 2020–2030 (US$ Million)
11. North America Aortic Valve Replacement Devices Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in North America Aortic Valve Replacement Devices Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Key Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 LivaNova Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica Industry, Commerce and Representations Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Artivion Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 JenaValve Technology Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Venus MedTech HangZhou Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Aortic Valve Replacement Devices Market Segmentation
Table 2. US Aortic Valve Replacement Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. US Aortic Valve Replacement Devices Market, by Surgery– Revenue and Forecast to 2030 (US$ Million)
Table 4. US Aortic Valve Replacement Devices Market, by End User– Revenue and Forecast to 2030 (US$ Million)
Table 5. Canada Aortic Valve Replacement Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 6. Canada Aortic Valve Replacement Devices Market, by Surgery– Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Aortic Valve Replacement Devices Market, by End User– Revenue and Forecast to 2030 (US$ Million)
Table 8. Mexico Aortic Valve Replacement Devices Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. Mexico Aortic Valve Replacement Devices Market, by Surgery– Revenue and Forecast to 2030 (US$ Million)
Table 10. Mexico Aortic Valve Replacement Devices Market, by End User– Revenue and Forecast to 2030 (US$ Million)
Table 11. Recent Organic Growth Strategies in Aortic Valve Replacement Devices Market
Table 12. Recent Inorganic Growth Strategies in the Aortic Valve Replacement Devices Market
Table 13. Glossary of Terms, North America Aortic Valve Replacement Devices Market
LIST OF FIGURES
Figure 1. North America Aortic Valve Replacement Devices Market Segmentation, By Country
Figure 2. North America – PEST Analysis
Figure 3. List of Vendors
Figure 4. North America Aortic Valve Replacement Devices Market – Key Industry Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. North America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 – 2030
Figure 7. North America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Mechanical Valve: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Sutureless Valve: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. North America Aortic Valve Replacement Devices Market Revenue Share, by Surgery 2022 & 2030 (%)
Figure 11. Open Surgery: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Minimally Invasive Surgery: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. North America Aortic Valve Replacement Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 14. Hospitals & Clinics: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Ambulatory Surgery Centers: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America: Aortic Valve Replacement Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 18. North America: North America Aortic Valve Replacement Devices Market, by Country, 2022 & 2030 (%)
Figure 19. US: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Canada: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Mexico: Aortic Valve Replacement Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Growth Strategies in North America Aortic Valve Replacement Devices Market
The List of Companies – North America Aortic Valve Replacement Devices Market
o Abbott Laboratories
o Artivion Inc
o Boston Scientific Corp
o Braile Biomedica Industry, Commerce and Representations Ltd
o Edwards Lifesciences Corp
o LivaNova Plc
o Medtronic Plc
o JenaValve Technology Inc
o Venus MedTech HangZhou Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.